JOHN CRAIG THOMPSON Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN CRAIG THOMPSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN CRAIG THOMPSON. JOHN CRAIG THOMPSON is a President & CEO in Anthera Pharmaceuticals Inc ($ANTH) and a President & COO in Anthera Pharmaceuticals Inc ($ANTH) and a Chief Commercial Officer in Trius Therapeutics Inc ($TSRX) and a Chief Operating Officer in TETRAPHASE PHARMACEUTICALS INC ($TTPH).
Address: C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 105 SAN DIEGO 92121 CA
Companies in which JOHN CRAIG THOMPSON is an Insider
Anthera Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN CRAIG THOMPSON: President & CEO, President & COO
Holdings: 19,848 shares
Current Value: $11,710
Latest Transaction: Jan 09 2018
$ANTH Market Capitalization: $23.84M
$ANTH Previous Close: $0.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TETRAPHASE PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN CRAIG THOMPSON: Chief Operating Officer
Holdings: 343 shares
Current Value: $1,434
Latest Transaction: Sep 10 2015
$TTPH Market Capitalization: $155.73M
$TTPH Previous Close: $4.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Trius Therapeutics Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN CRAIG THOMPSON: Chief Commercial Officer
Holdings: 0 shares
Latest Transaction: Mar 11 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN CRAIG THOMPSON
Sentiment: All, ANTH, TTPH, TSRX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 09 2018 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Option Exercise | A | 1.65 | 1,847,074 | 3,047,672 | 1,847,074 | |
| Sep 20 2017 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Buy | P | 1.32 | 8,550 | 11,286 | 19,848 | 11.3 K to 19.8 K (+75.68 %) |
| Sep 07 2017 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Buy | M | 1.43 | 10,400 | 14,893 | 17,590 | 7.2 K to 17.6 K (+144.65 %) |
| May 22 2017 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Option Exercise | A | 1.63 | 81,250 | 132,438 | 81,250 | |
| Mar 03 2017 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Option Exercise | A | 0.64 | 100,000 | 64,000 | 100,000 | |
| Dec 06 2016 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & CEO | Option Exercise | A | 1.47 | 300,000 | 441,000 | 300,000 | |
| Jun 13 2016 | ANTH | Anthera Pharmaceut ... | THOMPSON JOHN CRAIG | President & COO | Option Exercise | A | 3.52 | 170,000 | 598,400 | 170,000 |